Publisher： Bentham Science Publishers
E-ISSN： 2212-6988|2|1|61-70
ISSN： 2212-697x
Source： Clinical Cancer Drugs, Vol.2, Iss.1, 2015-05, pp. : 61-70
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Targeting the Ubiquitin E1 as a Novel Anti-Cancer Strategy
Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. :
Targeting Synthetic Lethality in DNA Damage Repair Pathways as an Anti-Cancer Strategy
Current Drug Targets, Vol. 11, Iss. 10, 2010-10 ,pp. :
Targeting Phosphatidylserine in Anti-Cancer Therapy
Current Pharmaceutical Design, Vol. 15, Iss. 23, 2009-08 ,pp. :
Targeting Multiplicity: The Key Factor for Anti-Cancer Nanoparticles
Current Medicinal Chemistry, Vol. 20, Iss. 15, 2013-05 ,pp. :